# Peripheral Ulcerative Keratitis: Pathogenesis, Diagnosis, and Multimodal Management

**Authors:** Jose Carlos Guerrero-Acosta, Gustavo Ortiz-Morales, Guillermo Raul Vera-Duarte, Alejandro Navas, Enrique O. Graue-Hernandez, Arturo Ramirez-Miranda

PMC · DOI: 10.3390/jcm15031264 · Journal of Clinical Medicine · 2026-02-05

## TL;DR

Peripheral ulcerative keratitis is a severe eye condition linked to autoimmune diseases, and this review summarizes its causes, diagnosis, and treatment options.

## Contribution

This paper provides a comprehensive review of PUK, emphasizing idiopathic forms like Mooren’s ulcer and multimodal treatment strategies.

## Key findings

- PUK is often associated with systemic autoimmune or vasculitic diseases.
- Management includes local and systemic therapies, with surgical options when needed.
- Immunological mechanisms like complement activation and matrix metalloproteinases play key roles in PUK.

## Abstract

Peripheral ulcerative keratitis (PUK) is a sight-threatening corneal disorder characterized by progressive peripheral stromal thinning and ulceration. It often reflects an underlying systemic autoimmune or vasculitic disease and may herald severe morbidity or even mortality. This review offers a comprehensive synthesis of current knowledge on the pathophysiology, clinical presentation, diagnostic approach, and management strategies for PUK, with a special focus on idiopathic forms such as Mooren’s ulcer. We explore the immunological mechanisms driving peripheral corneal destruction, including the roles of complement activation, matrix metalloproteinases, and systemic immune dysregulation. A detailed classification of etiologies, including systemic autoimmune diseases, infectious causes, and iatrogenic forms, is presented, along with recommendations for diagnosis, laboratory workup, and differential diagnosis. Management strategies are reviewed in a stepladder approach, from local anti-collagenase and immunomodulatory therapy to systemic immunosuppressants and biologics, and, when necessary, surgical intervention.

## Full-text entities

- **Diseases:** corneal destruction (MESH:D003316), PUK (MESH:D003320), immune dysregulation (OMIM:614878), autoimmune diseases (MESH:D001327), Mooren's ulcer (MESH:D014456)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898829/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12898829/full.md

## References

135 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898829/full.md

---
Source: https://tomesphere.com/paper/PMC12898829